Literature DB >> 20728213

Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation.

Xue-Feng Yu1, Zhengbo Sun, Min Li, Yang Xiang, Qu-Quan Wang, Fenfen Tang, Yingliang Wu, Zhijian Cao, Wenxin Li.   

Abstract

We report the development of neurotoxin-mediated upconversion nanoprobes for tumor targeting and visualization in living animals. The nanoprobes were synthesized by preparing polyethylenimine-coated hexagonal-phase NaYF(4):Yb,Er/Ce nanoparticles and conjugating them with recombinant chlorotoxin, a typical peptide neurotoxin that could bind with high specificity to many types of cancer cells. Nanoprobes that specifically targeted glioma cells were visualized by laser scanning upconversion fluorescence microscopy. Good probe biocompatibility was displayed with cellular and animal toxicity determinations. Animal studies were performed using Balb-c nude mice injected intravenously with the nanoprobes. The obtained high-contrast images demonstrated highly specific tumor binding and direct tumor visualization with bright red fluorescence under 980-nm near-infrared irradiation. The high sensitivity and high specificity of the neurotoxin-mediated upconversion nanoprobes and the simplification of the required optical device for tumor visualization suggest an approach that may help improve the effectiveness of the diagnostic and therapeutic modalities available for tumor patients.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728213     DOI: 10.1016/j.biomaterials.2010.07.099

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  20 in total

Review 1.  Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.

Authors:  Yuejun Fu; Na An; Ke Li; Yali Zheng; Aihua Liang
Journal:  J Neurooncol       Date:  2011-11-23       Impact factor: 4.130

2.  Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.

Authors:  Derek Reichel; Bien Sagong; James Teh; Yi Zhang; Shawn Wagner; Hongqiang Wang; Leland W K Chung; Pramod Butte; Keith L Black; John S Yu; J Manuel Perez
Journal:  ACS Nano       Date:  2020-06-23       Impact factor: 15.881

Review 3.  Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research.

Authors:  F Chen; W Bu; W Cai; J Shi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

4.  Radioactive (90Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.

Authors:  Evgenii L Guryev; Natalia O Volodina; Natalia Y Shilyagina; Sergey V Gudkov; Irina V Balalaeva; Arthur B Volovetskiy; Alexander V Lyubeshkin; Alexey V Sen'; Sergey A Ermilov; Vladimir A Vodeneev; Rem V Petrov; Andrei V Zvyagin; Zhores I Alferov; Sergey M Deyev
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-07       Impact factor: 11.205

Review 5.  Upconversion nanoparticles: design, nanochemistry, and applications in theranostics.

Authors:  Guanying Chen; Hailong Qiu; Paras N Prasad; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2014-03-10       Impact factor: 60.622

Review 6.  Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.

Authors:  Yongjun Cheng; Jinhua Zhao; Wenli Qiao; Kai Chen
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

7.  Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.

Authors:  Rui Zhang; Chiyi Xiong; Miao Huang; Min Zhou; Qian Huang; Xiaoxia Wen; Dong Liang; Chun Li
Journal:  Biomaterials       Date:  2011-05-25       Impact factor: 12.479

Review 8.  In vivo bio-imaging using chlorotoxin-based conjugates.

Authors:  Mark R Stroud; Stacey J Hansen; James M Olson
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

Review 9.  Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.

Authors:  Forrest M Kievit; Miqin Zhang
Journal:  Adv Mater       Date:  2011-08-15       Impact factor: 30.849

10.  Nanoparticles for Improving Cancer Diagnosis.

Authors:  Hongmin Chen; Zipeng Zhen; Trever Todd; Paul K Chu; Jin Xie
Journal:  Mater Sci Eng R Rep       Date:  2013-03       Impact factor: 36.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.